May 20, 2025
Headlines

Bankrupt 23andMe to be bought by pharmaceutical company Regeneron for $256 million

Justin M. Larson01 mins
83731693007 getty images 1978239010.jpg


Regeneron Pharmaceuticals has promised to comply with 23andMe’s existing privacy polices while also using data to fuel drug discovery.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News